Albertson Tina M.
- SEC CIK
- 0001917391
In the past year, 1 open-market sale filing worth $2.09K and no purchases.
Current role at each company
- CRBU Caribou Biosciences, Inc.Chief Medical Officeras of Feb 24, 2026
- LYEL Lyell Immunopharma, Inc.Chief Medical Officeras of Feb 28, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.09K
- 1 filing
- Net
- −$2.09K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Albertson Tina M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRBU Caribou Biosciences, Inc.
Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 (view filing) | Feb 24 | Same day | Albertson Tina M.Chief Medical Officer | SSale | −1.07K | $1.96 | −$2.09K | −1.5%68.5K after | 10b5-1 |